Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1033 vs Betahistine in BPPV
NCT07075289Phase 4Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Apr 2024
- Primary completion
- Aug 2024
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of DLBS1033 in benign paroxysmal positional vertigo (BPPV), sponsored by Universitas Sebelas Maret. Started Apr 2024; status: completed.
02
Drugs
DLBS1033
03
Conditions
benign paroxysmal positional vertigo (BPPV)
Beyond the preview
Go deeper on NCT07075289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07075289.